Valproic acid toxicity: overview and management (Q33963043)

30 July 2017

1 reference

title

Valproic acid toxicity: overview and management (English)

1 reference

30 July 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

39867

author name string

Matthew D Sztajnkrycer

series ordinal

1

1 reference

30 July 2017

publication date

1 January 2002

1 reference

Journal of Toxicology: Clinical Toxicology

30 July 2017

published in

1 reference

30 July 2017

volume

40

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

789-801

1 reference

Multiorgan system failure caused by valproic acid toxicity

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Comprehensive review of the psychiatric uses of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

1990 Annual report of the American Association of Poison Control Centers National Data Collection System

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Pharmacokinetics and bioavailability of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Concentration-effect relationships of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Life threatening intoxication with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Successful treatment of valproic acid overdose with hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Identification of Metabolites of Valproic Acid in Serum of Humans, Dog, Rat, and Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

The role of carnitine supplementation during valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Mechanisms of action of valproate: a commentatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

The action of valproate on spontaneous epileptiform activity in the absence of synaptic transmission and on evoked changes in [Ca2+]o and [K+]o in the hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Electrophysiologic analysis of the actions of valproate on pyramidal neurons in the rat hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Distribution of sodium valproate and GABA metabolism in CNS of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Effect of valproate on brain GABA: comparison with various medium chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Cerebral edema following acute sodium valproate overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Acute valproate intoxication with fatal outcome in an infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Effect of L-carnitine supplementation on acute valproate intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Pathophysiology of brain edema in fulminant hepatic failure, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Glutamine as a pathogenic factor in hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Unusual electronmicroscopic changes in valproate-associated liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Reye-like syndrome associated with valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Acute Hepatic Failure Associated with the Use of Sodium Valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Valproate-induced hyperammonemia of renal origin. Effects of valproate on glutamine transport in rat kidney mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Valproate induced encephalopathy treated with carnitine in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Carnitine, valproate, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Changes in urea cycle-related metabolites in the mouse after combined administration of valproic acid and an amino acid load

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Simultaneous "in series" hemodialysis and hemoperfusion in the management of valproic acid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

Treatment of accidental sodium valproate overdose with an opiate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120014645

21 January 2018

Identifiers

DOI

10.1081/CLT-120014645

1 reference

30 July 2017

1 reference